Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy

NCT05753462 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: Phase 1, SQY51
DRUG: Phase 2a, SQY51 (cohort 1)
DRUG: Phase 2a, SQY51 (cohort 2)
DRUG: Phase 2a, SQY51 (cohort 3)

Sponsor

Sqy Therapeutics

Collaborators

[object Object]